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X chromosome genetic variation has been proposed as a potential source of missing heritability for 
many complex diseases, including obesity. Currently, there is a lack of public available genetic datasets 
incorporating X chromosome genotype data. Although several X chromosome-specific statistics have 
been developed, there is also a lack of readily available implementations for routine analysis. Here, we 
aimed: (1) to make public and describe a dataset incorporating phenotype and X chromosome genotype 
data from a cohort of 915 normal-weight, overweight and obese children, and (2) to deeply describe a 
whole implementation of the special X chromosome analytic process in genetics. Datasets and pipelines 
like this are crucial to get familiar with the steps in which X chromosome requires special attention and 
may raise awareness of the importance of this genomic region.
Background & Summary
Overweight and obesity in children are a public health problem that has raised concern worldwide1. Childhood 
obesity is characterized by an expansion of the adipose tissue (AT)1 and plays an important role in the devel-
opment of cardiometabolic alterations during early adulthood, thereby increasing morbidity and mortality2. 
According to twin and family studies, around 40–70% of the interindividual variability in body mass index (BMI) 
has been attributed to genetic factors3–5. Despite this, known single-nucleotide polymorphisms (SNPs) explain 
<2% of BMI variation6, a phenomenon termed ‘missing heritability’. Potential sources explaining this missing 
heritability include epigenetic components, the existence of low frequency and rare variants as well as the pres-
ence of X chromosome genetic variation.
Analysis in current genetic association studies is usually focused on autosomal variants while the sex chro-
mosomes, and specially the X chromosome, are often neglected. Among the reasons, it highlights a lower gene 
density on the X chromosome, a lower coverage of the region in current genotyping platforms and a number 
of technical hurdles including complications in genotype calling, imputation and selection of test statistics7. 
According to a previous report, only 242 out of all 743 GWAS conducted from 2005 to 2011 considered the X 
chromosome in their analyses7. The proportion was similar when only family-based GWAS were considered. 
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There is therefore a lack of available public datasets including X chromosome genotype data for analysis. On the 
other hand, although several X chromosome-specific statistical tests and guidelines have now become available, 
there is also a lack of readily available implementations and user-friendly apps incorporating them for routine 
analysis8,9.
The majority of the technical hurdles faced when analysing X chromosomal data rise from two of its main 
particularities. The first one is the fact of women having two allele copies while males having only one. As a conse-
quence, if males are included in the analysis, special caution must be taken. Particularly, the study design process 
should be performed carefully, trying to maintain a balanced female/male ratio across experimental conditions. 
Otherwise, many available statistical tests will suffer from type I errors as soon as sex-specific allele frequencies 
occur, which is typically observed for a great number of variants. Other problems derived from an unbalanced sex 
ratio in the study sample include problems during the genotype calling process, as the signal intensities obtained 
from standard array genotyping platforms will be always lower in males than for females (who carry two alleles). 
The second uniqueness motivating X-chromosome specific analyses lies in the X chromosome inactivation (XCI) 
process, through which most of the cells of females express only one X chromosome allele in order to compensate 
the genetic dosage with regard to males. Before selecting a particular statistical approach, it should be mandatory 
to carefully investigate the concrete XCI model to assume for a gene in a particular tissue. Depending on the XCI 
model assumed, we should proceed one way or another during the selection of the test statistics. These and other 
particularities must be addressed as long as X chromosomal data are included into genetic studies.
In relation to obesity, only a few studies have reported association with markers on the X chromosome. One 
of the most remarkable findings involves the tenomodulin (TNMD) gene, a Xq22 located locus encoding a type 
II transmembrane glycoprotein. First time associated with adult obesity at the genetic level10, its presence in adult 
human AT has been demonstrated showing higher expression in obesity and lower expression after diet-induced 
weight loss. Regarding children population, our research group found that TNMD expression was five fold-times 
up-regulated in visceral adipose tissue (VAT) of children with obesity, compared with their normal-weight counter-
parts (Gene Expression Omnibus GSE9624)11,12. Recently, we have reported new associations between TNMD SNPs 
and childhood obesity and metabolic alterations in a Spanish children population13. Interestingly, our study has been 
the first to analyse and detect associations between X chromosome TNMD genetic variants and obesity in a children 
cohort. Similarly, SNPs in the SLC6A14 gene, also located in the X chromosome, have shown evidence of association 
with obesity14. As a whole, these TNMD and SLC6A14 reports support the fact that X chromosome genetic variants 
may be not only useful early life risk indicators of obesity but also an interesting source of missing heritability13.
Given the lack of public available genetic datasets incorporating X chromosome genetic variants and the still 
prevalent statistical hurdles that make the X chromosome a difficult region to be tested in functional genetics, 
we here aimed: (1) to make public and describe a dataset incorporating X chromosome genotype data from a 
children cohort13,15, and (2) to outline a whole implementation of the special X chromosome analytic process 
in genetics. The presented research dataset includes X-chromosomal SNP data (mapping the genes TNMD and 
SLC6A14) from a children cohort composed of 915 normal-weight, overweight and obese subjects. Some topics 
covered in this paper include dataset sharing and description, explanation of sample design, genotype calling, 
quality control, and test statistics selection procedures. Additionally, a short section explaining and interpreting 
findings obtained after analysing the dataset with a specific X chromosome analytic approach is presented.
Methods
experimental design and study population. These methods are an expanded version of descriptions 
in our related work and general characteristics of the dataset have been previously described13. Briefly, in this 
case-control multicentre study, 915 Spanish children (438 males and 477 females) were recruited from three 
national health institutions: Lozano Blesa University Clinical Hospital, Santiago de Compostela University 
Clinical Hospital and Reina Sofía University Clinical Hospital. According to specific X-chromosomal analytic 
requirements, the female/male ratio of the study sample was perfectly balanced.
Childhood obesity status was defined according to the International Obesity Task Force (IOTF) reference 
for children16 which is based on the application, on children population, of the widely used cut-off points of 
BMI for adults (25 and 30 kg/m2, for overweight and obesity respectively). Particularly, these criteria constitute 
a range of age and sex specific cut-off points for children that have been extracted from solid percentile tables 
constructed on 97876 boys and 94851 girls ranging from 2 to 18 years. After the application these specific cut-off 
points, the dataset was composed of 480 children in the obesity group, 177 in the overweight group and 258 in the 
normal-BMI group. Children were allocated into two experimental  conditions according to their obesity status; 
the affected group (cases) composed of both children with obesity or overweight and the control group composed 
of normal-weight children. An unbalanced female/male ratio across cases and controls has been proven to heavily 
affect the power of some specific X chromosome association tests17. In our study, a balanced female/male ratio 
was maintained across each experimental condition (122/136 in controls and 355/302 in cases) (Fig. 1).
Inclusion criteria were European-Caucasian heritage and the absence of congenital metabolic diseases. 
Otherwise, the exclusion criteria were non-European Caucasian heritage, the presence of congenital metabolic 
diseases (e.g., diabetes or hyperlipidemia), undernutrition, and the use of medication that alters blood pressure, 
glucose or lipid metabolism.
ethical statement. All procedures in the study were conducted in accordance with the Declaration of 
Helsinki (Edinburgh 2000 revised), and followed the recommendations of both the Good Clinical Practice of the 
CEE (Document 111/3976/88 July 1990) and the legally enforced Spanish regulation for clinical investigation of 
human beings (RD 223/04 about clinical trials). The Ethics Committees on Human Research of all participant 
institutions approved all experiments and analyses with registration Code: “2011/198”. All parents or guardians 
provided written informed consent and children gave their assent.
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DNa extraction, processing and analysis. The presented dataset consists on genotype data for eight 
target SNPs mapping the X-chromosomal genes TNMD and SLC6A14 in the study population. Details regarding 
SNP selection and molecular analyses are briefly covered here since they have already been fully detailed in our 
previous work13. On the contrary, we pay special attention in the explanation of X chromosomal particularities, 
data description as well as in the summarization of each data analysis and processing step.
Seven SNPs located at the TNMD locus and one located at the SLC6A14 were selected for genotyping analy-
sis. Genomic DNA was extracted from peripheral white blood cells using two automated kits, the Qiamp DNA 
Investigator Kit for coagulated samples and the Qiamp DNA Mini & Blood Mini Kit for non-coagulated samples 
(QIAgen Systems, Inc., Valencia, CA, USA). All extractions were purified using the DNA Clean and Concentrator 
kit from Zymo Research (Zymo Research, Irvine, CA, USA). Genotyping was performed by TaqMan allelic dis-
crimination assay using the QuantStudio 12 K Flex Real-Time PCR System (Thermo Fisher Scientific, Waltham, 
MA, USA). Given the X-chromosomal location, it is recommendable to analyse females and males in separate 
plates during the genotyping process or, at least, maintain a balanced female/male ratio by plate.
Once genotyping was accomplished, we checked candidate SNPs for sex-specific allele frequencies, which can 
induce type I errors in some statistical X-chromosome analyses (especially in the case of unbalanced designs). 
Tested by means of the Fisher exact test, all SNPs in the TNMD showed no significant P-values and thus equal 
allele frequencies across sex groups (Table 1). On the contrary, the SNP in the SLC6A14 did not (P = 0.01). This 
fact should be taken into consideration when selecting an appropriate test for high-level statistical analyses 
unless a balanced sex ratio across experimental conditions is presented in the population (which is our case). 
Information regarding minor allele frequencies (MAFs) stratified by experimental condition for all candidate 
a.
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Fig 1 Study design and characteristics. (a) Experimental workflow used to generate and analyse the data. (b) 
Genomic context of selected markers; light blue boxes represent exons, while the connecting lines are introns. 
Abbreviations; rs, reference SNP; UTR, untranslated region.
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markers is presented in (Table 2). Linkage disequilibrium (LD) status of the TNMD gene was studied using the 
Haploview Software separately in males and females13,18.
Data Records
The complete research dataset (genotype and phenotype data) has been uploaded into the European 
Genome-Phenome archive (EGA). The work can be found online with the title “X chromosomal genetic variants 
are associated with childhood obesity” or with the identifier EGAS00001002738 (2018)15. Online data are sorted 
and presented according to obesity status; the affected group (cases) composed of both children with obesity or 
overweight (EGA reference EGAD00010001482 (2018)) and the control group composed of normal-weight chil-
dren (EGA reference EGAD00010001481 (2018)). Three files by-experimental condition (a total of six) are available 
online (.bed, bim and fam files). The bed files contain raw genotype data while the bim files describe information 
relative to target SNPs (chromosome number, SNP identifier, genetic distance in morgans (set as 0 for all markers), 
base-pair position and coding alleles). Instead, the fam files contain information relative to subjects (sample iden-
tifiers, family and paternal identifiers (here set as 0), sex (1 for males and 2 for females) and experimental group (1 
CHR SNP BP A1 MAF (All) MAF (Females) MAF (Males) A2 P OR
23 rs11798018 100584572 A 0.26 0.26 0.27 C 0.84 0.97
23 rs5966709 100589508 T 0.32 0.32 0.31 G 0.75 1.05
23 rs4828037 100590686 C 0.34 0.34 0.33 T 0.53 1.08
23 rs2073162 100594019 A 0.45 0.45 0.42 G 0.37 1.12
23 rs2073163 100594053 C 0.45 0.46 0.43 T 0.35 1.13
23 rs4828038 100596678 T 0.44 0.45 0.42 C 0.31 1.13
23 rs1155974 100598283 T 0.44 0.44 0.42 C 0.59 1.07
23 rs2011162 116459132 C 0.34 0.37 0.30 G 0.02* 1.36
Table 1. Allele frequencies in the whole study population and each sex group. P and OR columns correspond 
to P-values and odd ratios obtained by means of the Fisher exact test for sex-specific allele frequencies (sex 
differences in allele frequency per SNP). *P < 0.05. Abbreviations; CHR, Chromosome; SNP, Single Nucleotide 
Polymorphism; BP, Base Pair; A1, Minor Allele; MAF, Minor Allele Frequency; A2, Alternative Allele.
CHR SNP GROUP A1 MAF
23 rs11798018 OVERWEIGHT A 0.26
23 rs11798018 OBESITY A 0.27
23 rs11798018 NORMAL-BMI A 0.28
23 rs5966709 OVERWEIGHT T 0.29
23 rs5966709 OBESITY T 0.34
23 rs5966709 NORMAL-BMI T 0.30
23 rs4828037 OVERWEIGHT C 0.32
23 rs4828037 OBESITY C 0.36
23 rs4828037 NORMAL-BMI C 0.31
23 rs2073162 OVERWEIGHT A 0.44
23 rs2073162 OBESITY A 0.46
23 rs2073162 NORMAL-BMI A 0.43
23 rs2073163 OVERWEIGHT C 0.45
23 rs2073163 OBESITY C 0.47
23 rs2073163 NORMAL-BMI C 0.43
23 rs4828038 OVERWEIGHT T 0.43
23 rs4828038 OBESITY T 0.46
23 rs4828038 NORMAL-BMI T 0.43
23 rs1155974 OVERWEIGHT T 0.42
23 rs1155974 OBESITY T 0.45
23 rs1155974 NORMAL-BMI T 0.43
23 rs2011162 OVERWEIGHT C 0.34
23 rs2011162 OBESITY C 0.36
23 rs2011162 NORMAL-BMI C 0.34
Table 2. Allele frequencies in the study population stratified by experimental condition. Abbreviations; CHR, 
Chromosome; SNP, Single Nucleotide Polymorphism; BMI, Body Mass Index; A1, Minor Allele; MAF, Minor 
Allele Frequency.
5Scientific Data |           (2019) 6:130  | https://doi.org/10.1038/s41597-019-0109-3
www.nature.com/scientificdatawww.nature.com/scientificdata/
for control and 2 for cases)). All presented formats can be easily readable in PLINK 1.9 software using the –bfile 
command option and further transformed into a more standard file format with the –dosage option19.
The complete data set in the current study complies with the requirements of the EGA archive. Detailed infor-
mation about each sample and shared data files is presented in Online-only Tables 1 and 2, and Supplementary 
File 1. Specifically, DOI and descriptions for each shared file are provided in the Online-only Table 2.
technical Validation
X chromosome particularities. Before introducing further steps, we here list two issues making the X 
chromosome a difficult region for genetic analyses. These particularities will determine important decisions 
related to genotype calling, data imputation and statistical analysis. It is important to note, however, that all 
here-described particularities are only applicable to those X chromosomal loci outside the pseudo-autosomal 
region of the X chromosome (which is the case of TNMD and SLC6A14).
The first noticeable uniqueness of the X chromosome is the fact of women having two allele copies while 
males having only one. As a result, while females can present the standard three possible allele combinations (AA, 
AB and BB), males are homozygous and have only two distinct possible genotypes (A- and B-). For this reason, 
standard autosomal association tests, such as the Cochran-Armitage trend test20,21, are not immediately applicable 
to X chromosome data. The second particularity affecting the X-chromosome analysis lies in the X chromosome 
inactivation (XCI) process, through which the transcription from one of the two X chromosome copies in female 
mammalian cells is silenced in order to balance the expression dosage between XX females and XY males. XCI is, 
however, incomplete in humans: with up to one-third of the X-chromosomal genes escaping from this silencing 
epigenetic mechanism. The degree of ‘escape’ from inactivation has been reported to strongly vary between genes, 
tissues and individuals22,23, with three possible scenarios at the gene level: complete XCI, partial XCI or total 
escape from XCI24,25. Depending on the XCI model assumed for a certain gene, we should proceed one way or 
another during the selection of the test statistics (see section ‘High-Level Analysis: Statistical Analysis’ for further 
details). The assumption of a particular XCI model is therefore a process that must be performed carefully.
Until date, the extent to which XCI is shared between cells and tissues remains poorly characterized and there 
is a lack of standardized criteria nor well-established databases to check if a gene escapes or not from XCI in a 
concrete situation. In order to do so, an exhaustive search in PUBMED and other scientific databases should 
be performed looking for particular studies supporting a certain XCI hypothesis. Currently, the most similar 
resource to a standardized database on this regard is the initiative carried out by the Genotype-Tissue Expression 
(GTEx) consortium9 in 2017, which describes a systematic survey of XCI, integrating over 5500 transcriptomes 
from 449 Individuals, spanning 29 tissues from the GTEx (v6p release) and 940 single-cell transcriptomes, com-
bined with genomic sequence data. Particularly, they show that XCI at 683 X-chromosomal genes is generally 
uniform across human tissues and that incomplete XCI affects at least 23% of X-chromosomal genes. Overall, this 
work presents an updated catalogue of XCI across human tissues which may be of great utility during the selec-
tion of a particular XCI model for a gene. Other available resources also include the work of Slavney et al.26, which 
gathers the main XCI insights from previous studies on X-chromosome gene expression datasets.
By way of example, we here illustrate the whole process followed for the identification of the optimal XCI model in 
the case of TNMD. First, we interrogated the Slanvey et al. (2016) work26, where no evidence of escape from XCI was 
reported. In order to get more information about this fact, we further studied in detail the three works summarized in 
the Slanvey et al.26 paper. The first work on which the paper is based is a study from Carrel et al.22, in which we could 
not identify any probe covering the TNMD region. Instead, a few surrounding regions were mapped; among which 
the SRPX2, ZD89B07 and the SYTL4 reported escaping from the XCI process. In spite of it, this study was based on a 
fibroblast cell model and thus not applicable to our adipose tissue context. Regarding the second revised article27, again, 
there were not available probes covering TNMD. Thus, neither conclusions nor new information could be extracted. In 
relation to the third included article28, we were not able to find any table or supplemental material showing an output 
list of the analysed regions. Next, we investigated the well-established work from the GTEx consortium9 and found that 
the XCI status of the TNMD region remains catalogued as unknown (Supplementary Tables S2 and S13 of this paper). 
As a complementary approach, we performed a search in PUBMEP looking for individual studies focused on the gene 
expression status of TNMD from different sexes. As a result, we found a work reporting higher basal expression of 
TNMD in women than in men29, which could indicate that TNMD escapes from the XCI.
Taking all this into consideration and given the lack of agreement, both possibilities (‘escape from XCI’ and 
‘XCI’) should be tested in the case of TNMD. A searching process like this is highly recommendable to be done 
for any X chromosome locus before the selection of a particular statistical approach.
Raw data processing. The primary step of the data analysis consisted on the extraction of genotype calls 
from fluorescence array data and the construction of work data files for data manipulation and analysis. Details 
regarding the exact procedure for genotype calling, which is an important procedure in X-chromosomal analyses, 
are listed below (‘Genotype Calling’ section).
Once we obtained genotype calls for the 915 individuals, we generated standard format files (.ped and .map) 
transforming the ThermoFisher cloud-derived outputs from long to wide format using an own script in R envi-
ronment30. Finally, data were imported into PLINK 1.9 software19 and converted into binary format files using 
the –make-bed flag. These binary formats (.bed, .bim and .fam) are a more compact representation of the data that 
saves space and speeds up subsequent analyses.
Genotype calling. This is the first step of any primary genotype analysis and consists on the extraction of 
genotype calls from fluorescence array data at the SNP and individual level. Along with the test statistics selection 
procedure, the genotype calling process is an analytical step heavily affected by X chromosome particularities. 
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Specifically, the main X chromosome uniqueness affecting this process is the dosage imbalance between males 
and females. Since males carry only one X allele, signal intensities obtained from the Real-Time PCR System are 
lower in males than for females and thus a correction should be implemented. On this matter, calling algorithms 
which apply different models to male and female samples (e.g. Illuminus and CRLMM) have been proven to gen-
erally perform better than methods which do not (e.g. GenCall and GenoSNP)31.
Here, we employed the Applied Biosystems qPCR app module (Thermo Fisher Cloud software) and the auto-
calling method for genotype calling. According to literature recommendations, the sex information for each 
sample was supplied to the software and genotype calling was performed separately in both sexes. In this regard, 
although genotyped plates did not consist on only boys or girls, the balanced sex ratio of our population (477 
females and 438 males) favoured a better performance of the algorithm. Five signal clusters were identified (three 
in the case of females and two in the case of males). Then, sex information and scatter of the clusters were used to 
call the genotypes (AA, AB and BB for females, and A- and B- for males). Since the employed software also allows 
CHR SNP
MISS FREQ 
(Males)
MISS FREQ 
(Females)
MISS FREQ 
(Males-Females) P
23 rs11798018 0.11 0.04 0.07 2.01e-05
23 rs5966709 0.06 0.004 0.06 3.11e-07
23 rs4828037 0.06 0.01 0.05 3.46e-05
23 rs2073162 0.08 0.008 0.07 2.86e-08
23 rs2073163 0.14 0.09 0.05 0.02
23 rs4828038 0.07 0.002 0.07 4.19e-10
23 rs1155974 0.08 0.002 0.07 9.73e-11
23 rs2011162 0.07 0.02 0.05 9.30e-05
Table 3. Missing frequency quality control (QC) in our selected markers stratified by sex. P column correspond 
to differential missingness test between sex groups. Asymptotic p-values were obtained by means of Fisher’s 
exact test. SNPs in bold did pass the QC recommended filters. Abbreviations; CHR, Chromosome; SNP, Single 
Nucleotide Polymorphism; MISS FREQ, Missing Frequency.
CHR SNP TEST A1 GENO O(HET) E(HET) P
23 rs11798018 ALL A 34/177/249 0.38 0.39 0.72
23 rs11798018 AFF A 25/133/187 0.38 0.39 0.89
23 rs11798018 UNAFF A 9/44/61 0.39 0.40 0.81
23 rs5966709 ALL T 67/175/234 0.37 0.44 0.0005
23 rs5966709 AFF T 55/128/171 0.36 0.45 0.0005
23 rs5966709 UNAFF T 12/46/63 0.38 0.41 0.38
23 rs4828037 ALL C 75/178/219 0.38 0.45 0.0003
23 rs4828037 AFF C 63/129/158 0.37 0.46 0.0001
23 rs4828037 UNAFF C 12/48/61 0.40 0.42 0.66
23 rs2073162 ALL A 132/172/170 0.36 0.50 4.59e-09
23 rs2073162 AFF A 99/128/124 0.36 0.50 6.78e-07
23 rs2073162 UNAFF A 33/43/46 0.35 0.49 0.002
23 rs2073163 ALL C 129/148/156 0.34 0.50 6.92e-011
23 rs2073163 AFF C 98/112/113 0.35 0.50 3.83e-08
23 rs2073163 UNAFF C 31/35/43 0.32 0.49 0.0002
23 rs4828038 ALL T 133/171/173 0.36 0.50 1.56e-09
23 rs4828038 AFF T 100/128/127 0.36 0.50 2.49e-07
23 rs4828038 UNAFF T 33/43/46 0.35 0.49 0.002
23 rs1155974 ALL T 127/172/178 0.36 0.49 4.18e-09
23 rs1155974 AFF T 94/128/132 0.36 0.49 4.02e-07
23 rs1155974 UNAFF T 33/43/46 0.35 0.49 0.002
23 rs2011162 ALL C 84/179/207 0.38 0.47 0.0001
23 rs2011162 AFF C 62/136/150 0.39 0.47 0.003
23 rs2011162 UNAFF C 22/42/57 0.35 0.46 0.01
Table 4. Genotype counts and Hardy-Weinberg test statistics for each SNP in the female group. Each SNP 
has three entries showing results for either ALL individuals, AFF (overweight and children with obesity) or 
UNAFF (normal-BMI children only). Hardy Weinberg analysis was performed with the exact test described and 
implemented by Wigginton et al.42. Abbreviations; CHR, Chromosome; SNP, Single Nucleotide Polymorphism; 
A1, minor allele; GENO, genotype counts; O(HET), observed heterozygosity; E(HET), expected heterozygosity; 
P, hardy weinberg P-value.
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the option of applying user-definable boundaries for data analysis, those samples classified as undetermined by 
the autocalling method were recalled using the manual option. A set of controls were used to deduce these ques-
tionable genotype calls. Outliers were omitted from the analysis.
Data QC. Prior to high-level statistical analyses, the quality control (QC) process is an important step in any 
genetic analysis and especially in the X-chromosome analysis. Specific QC guidelines for X chromosome geno-
type data have been previously reviewed in detail8. All these criteria can help us to detect genotype errors or not 
reliable SNPs which should be excluded from analysis.
Here, the whole QC process was implemented in PLINK 1.9 software19. According to literature, two criteria 
concerning missing frequency were employed (the sex-specific missing frequency and the differential missing-
ness between sexes)32,33. As genotype calling was performed separately in males and females (that is, no heterozy-
gote calls in males were allowed), the proportion of heterozygote calls in males, proposed as a filter criterion by 
Ling and Ziegler et al.32,33, was not considered in our QC process. All SNPs (with exception of the rs11798018 
and the rs2073163 from the TNMD gene) passed the recommended missing frequency filter in females (<=2%) 
(Table 3). On the other hand, none SNP passed the filter in males. Regarding the differential missingness test, the 
SNPs (rs11798018, rs4828037 and rs2073163) from the TNMD and the rs2011162 from the SLC6A14, passed the 
recommended filter (P ≥ 10−7). The other SNPs, instead, evidenced a marked differential missingness between 
sex groups. This test was performed in PLINK software using the flag “test-missing” and replacing the phenotype 
column of the ped file by the sex information (Table 3).
Regarding additional MAF quality checks, all SNPs showed appropriated frequencies >1% by sex groups 
(Table 1). When analysing the Hardy Weinberg equilibrium (HWE) in girls belonging to the normal-BMI group, 
all SNPs reported proper values (P ≥ 10−4) (Table 4). According to this QC process, we ensured that there were 
not important genotyping errors and that our genetic data were reliable for further analyses.
On this point, it is important to note that since genotyping array technologies are not specially designed for 
sexual chromosomes, quality is always hoped to be lower on X chromosome genetic variants compared to auto-
somal data.
High-level analysis: statistical analysis. As we previously mentioned, most of available test statistics 
for performing genetic association analyses have been  designed for autosomal variants and thus they are not 
applicable to X chromosome data (especially when dealing with mixed-sex samples). In these cases, testing for 
association on the X chromosome raises unique challenges that have motivated the development of X-specific 
statistical tests in the literature34,35. Association tests on the X chromosome should incorporate into their models 
not only the fact of dosage imbalance between males and females but also, depending on the analysed locus, a 
specific XCI model. Some of available approaches include:
•	 Clayton Tests (2008)34. Clayton tests are two X chromosome specific versions of the common autosomal tests 
that explicitly account for the XCI process and allow the inclusion of males and females together. In the case 
of different allele frequencies in males and females, Clayton statistics have inflated type I error frequencies. 
These tests are available in the R package snpMatrix36 with the names:
•	 S134: It is analogous to a Cochran-Armitage trend test of a combined male and female genotype contin-
gency table; it follows a Chi² distribution on one degree freedom (df) under the null hypothesis.
•	 S234: It is analogous to a Pearson’s Chi² test on 2 df of a combined male and female genotype contingency 
table, it follows a Chi² distribution on 2 df under the null hypothesis.
•	 Zheng tests (2007)35. They are a set of six different statistics that apply to the same SNP and from which a 
minimum P-value is computed, needing to be adjusted according to the correlation between the test statistics. 
Zheng et al.35 showed that the optimal choice of statistic among the six tests depends on whether HWE holds 
at the locus and whether males and females have the same risk allele. For example, in the case there is depar-
ture from HWE in females, the Zheng (Z2mfG) test has been presented a good choice. For further information 
regarding test statistic selection, we recommend to read works8,35. Of note is that the Zheng’s tests do not 
explicitly account for the XCI process.
As previously mentioned, an unbalanced female/male ratio between cases and control would affect the relative 
power of both Zheng and Clayton statistics. If combined with sex-specific allele frequencies, these tests will suffer 
from increased type I errors.
•	 Traditional methods easily implementable in PLINK 1.9 or R environment:
•	 Ignore males entirely and analyse female data using conventional autosomal tests (a genotypic-based 
Cochran-Armitage trend test or an allele-based Chi² by Pearson with 1 df). The problem related to this 
approach is that we are missing all data from male subjects and therefore losing statistical power. The 
Cochran-Armitage trend test is the default test employed when a naive analysis of X chromosome data is 
run in PLINK using the flag –model19. Regarding males, an allele-based test accounting for the number of 
A- and B- alleles between experimental conditions should be employed apart.
•	 Linear or logistic regression analyses on all the samples adjusting by sex. This approach further has the 
advantage of adjusting the model by covariates of interest. Here, if we assume that the locus of interest 
escapes from XCI, females should be coded as 0, 1, or 2, according to 0, 1, or 2 number of SNP risk 
alleles, and males should be coded as 0 or 1 according to 0 or 1 allele copies. On the contrary, if XCI is 
8Scientific Data |           (2019) 6:130  | https://doi.org/10.1038/s41597-019-0109-3
www.nature.com/scientificdatawww.nature.com/scientificdata/
assumed to occur, females should be coded as 0, 1, or 2, according to 0, 1, or 2 number of SNP risk alleles, 
and males should be coded as 0 or 2 according to 0 or 1 allele copies. By default, the application of the 
“–dosage” flag to X chromosome input data files (.bed, bim and fam) in PLINK will produce a codification 
which assumes escape from XCI. For XCI to be considered, new allele code numbers should be manually 
replaced in male samples with a standard text editor (e.g: gedit software).
In general, the selection of the most suitable test among the presented choices will depend on three different 
criteria; the XCI model assumed for the locus of interest, deviation from HWE of analysed markers and the exist-
ence of sex-specific allele frequencies in the study population, which would be a substantial problem in the case 
of an unbalanced female/male ratio. Regarding XCI, if inactivation is assumed to occur, then either the Clayton’s 
statistics or regression models (with males coded as 0 and 2 (for 0 and 1 risk allele, respectively)) would be the 
tests of choice. On the contrary, in the case of a locus ‘escaping’ from XCI, Zheng’s tests or regression models (with 
males coded as 0 and 1 (for 0 and 1 risk allele, respectively)) should be employed. In the case of sex-specific allele 
frequencies, independently of the XCI assumed model, the Zheng’s test (Z2mfG) has been presented a better choice 
over the Clayton approach. On the other hand, in the case of an adjustment for covariates is required, only regres-
sion models can be applied. Of note is that most of the test statistics and analysis considerations covered here are 
available to implement in  the command-line toolset XWAS developed by Keinan A. and collaborators37–39.
Although for the analysis of our dataset both possibilities (‘escape from XCI’ and ‘XCI’) were tested in the orig-
inal work13, we here only present results under the XCI assumption. As we have previously seen, selected markers 
in our sample did not exhibit HWE deviations nor sex-specific allele frequencies. Moreover, the female/male ratio 
was balanced across experimental groups. For these reasons, and following published recommendations8,17,34,40, 
Clayton test was here selected to perform the main statistical analysis. According to an in silico simulation work, 
the Clayton’s S1 statistic has shown the best performance among all X-specific introduced tests across a wide 
range of disease models, sex ratios and allele frequencies40. Moreover, it allows the inclusion of females and males 
together, increasing thereby the statistical power.
SNP N Chi.squared.1.df Chi.squared.2.df P.1df P.2df
HOMA-IR
rs11798018 811 0.10 1.68 0.74 0.43
rs5966709 849 0.14 2.71 0.70 0.25
rs4828037 844 0.35 2.91 0.55 0.23
rs2073162 841 5.48 6.34 0.01 0.04
rs2073163 773 4.78 5.93 0.02 0.05
rs4828038 849 6.00 7.24 0.01 0.02
rs1155974 844 4.22 6.68 0.03 0.03
rs2011162 839 0.48 0.91 0.48 0.63
Glucose (mg/dl)
rs11798018 844 0.004 1.06 0.94 0.58
rs5966709 881 0.55 0.59 0.45 0.74
rs4828037 876 1.22 1.25 0.26 0.53
rs2073162 873 5.17 8.13 0.02 0.01
rs2073163 804 2.8 4.006 0.09 0.13
rs4828038 880 4.78 6.42 0.02 0.04
rs1155974 876 3.94 4.74 0.04 0.09
rs2011162 871 0.92 3.55 0.33 0.16
BMI z-score
rs11798018 845 0.97 1.15 0.32 0.56
rs5966709 881 0.77 1.21 0.37 0.54
rs4828037 877 0.51 0.51 0.47 0.77
rs2073162 872 8.61 9.59 0.003 0.008
rs2073163 803 7.09 8.60 0.007 0.01
rs4828038 877 9.02 10.38 0.002 0.005
rs1155974 875 7.75 8.69 0.005 0.01
rs2011162 871 3.31 5.33 0.06 0.06
Table 5. Association between X chromosome SNPs and HOMA-IR, Glucose and BMI z-score in our dataset. 
SNPs in bold showed statistically significant associations with presented phenotypes under Clayton Statistics. 
This test explicitly accounts for random X-inactivation and allows the inclusion of females and males together, 
increasing thereby the statistical power. P.1df and Chi.squared.1.df columns corresponds to Clayton S1 
statistic results while P.2df and Chi.squared.2.df corresponds to Clayton S2 statistic. Abbreviations; SNP, Single 
Nucleotide Polymorphism; N, number of included subjects in the analysis; HOMA-IR, homeostasis model 
assessment for insulin resistance; BMI z-score, body mass index adjusted by sex and age.
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In Table 5, results derived from the application of Clayton’s S1 and S2 statistics to three different continuous 
phenotypes of the population are presented. All these phenotype data have also been shared and are available 
in the metadata file (Online-only Table 1). The implementation of this process was performed in R, using the 
snpStats R package and the code have been shared online41. All reported associations in our previous work13 were 
here replicated under XCI assumption. These findings support therefore a good performance of the Clayton sta-
tistics as well as ensure the reliability of the present dataset.
In conclusion, we here share a genetic dataset and present a whole implementation of the special X chro-
mosome analytic process in genetics. Altogether, the pipeline and the shared data will allow researchers to get 
familiar with the X chromosome particularities and should encourage them to include X chromosome into their 
genetic studies. Closing this gap is crucial to elucidate the genetic background of complex diseases, especially of 
those with sex-specific features.
Code availability
All custom R codes employed in this work have been shared online in a GitHub repository (10.5281/
zenodo.2578182)41. Two short scripts are available online; “script_from_long_to_wide.r” and “Clayton_analysis_
code.r”.
The first one (named “script_from_long_to_wide.r”) is a short script designed for loading a genetic dataset 
(genotype calls) derived from OpenArray technology and transforming it into a handy-format file, which can be 
further imported into PLINK software. Basically, this script carries out a dataset manipulation and transforma-
tion from long to wide format. In order to run the script, users will need an input file derived from OpenArray 
technology containing information in the long format arranged into three columns (NCBI_SNP_Reference, 
Sample_ID and Genotype_Call).
The second script shared (named “Clayton_analysis_code.r”) gathers functions and R commands required for 
the application of the X-chromosome specific statistical tests developed by Clayton and collaborators34,36 (see 
section ‘High-Level Analysis: Statistical Analysis’ for further details).
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